Cetera Investment Advisers Raises Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Cetera Investment Advisers boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 6.3% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 22,244 shares of the medical device company’s stock after purchasing an additional 1,309 shares during the quarter. Cetera Investment Advisers’ holdings in Cooper Companies were worth $1,942,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. LRI Investments LLC increased its stake in Cooper Companies by 4.5% during the 2nd quarter. LRI Investments LLC now owns 2,595 shares of the medical device company’s stock valued at $227,000 after purchasing an additional 112 shares in the last quarter. Commonwealth Equity Services LLC increased its holdings in shares of Cooper Companies by 0.8% in the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock worth $1,362,000 after purchasing an additional 118 shares in the last quarter. First Horizon Advisors Inc. raised its stake in shares of Cooper Companies by 4.8% in the second quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock worth $236,000 after purchasing an additional 125 shares during the last quarter. American International Group Inc. lifted its holdings in shares of Cooper Companies by 1.0% during the fourth quarter. American International Group Inc. now owns 13,229 shares of the medical device company’s stock valued at $5,006,000 after purchasing an additional 137 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV increased its holdings in Cooper Companies by 18.7% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 996 shares of the medical device company’s stock worth $87,000 after buying an additional 157 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on COO shares. Robert W. Baird raised their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Wells Fargo & Company increased their price objective on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and boosted their target price for the company from $107.00 to $115.00 in a research report on Tuesday, July 16th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and a consensus target price of $115.00.

Cooper Companies Stock Up 0.4 %

Shares of COO opened at $106.74 on Monday. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $112.38. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $21.25 billion, a PE ratio of 62.79, a price-to-earnings-growth ratio of 2.56 and a beta of 0.98. The business’s 50 day moving average is $102.73 and its 200 day moving average is $96.13.

Cooper Companies (NASDAQ:COO) last released its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.91 by $0.05. The firm had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.84 earnings per share. Research analysts expect that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Insider Buying and Selling at Cooper Companies

In other news, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at $18,267,624.69. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Albert G. White III sold 114,992 shares of the business’s stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the transaction, the chief accounting officer now directly owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock worth $27,637,427 in the last quarter. 2.00% of the stock is owned by corporate insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.